Benzinga's Top Upgrades, Downgrades For July 18, 2019

Top Upgrades

• Raymond James upgraded Skyworks Solutions Inc SWKS from Market Perform to Outperform. Skyworks fell 0.8% to $79.50 in pre-market trading.
• Bank of America upgraded U.S. Bancorp USB from Underperform to Neutral. US Bancorp rose 2.2% to close at $54.22 on Wednesday.
• Keefe Bruyette & Woods upgraded Bank of New York Mellon Corp BK from Underperform to Market Perform. Bank of New York Mellon shares rose 2.3% to close at $44.12 on Wednesday.
• BMO Capital upgraded TreeHouse Foods Inc. THS from Market Perform to Outperform. Treehouse Foods shares fell 0.4% to close at $54.54 on Wednesday.
• Analysts at Scotiabank upgraded PriceSmart, Inc. PSMT from Sector Perform to Sector Outperform. Pricesmart shares fell 0.8% to close at $61.70 on Wednesday.
• Raymond James upgraded Apple Inc. AAPL from Market Perform to Outperform. Apple shares rose 0.3% to $204.00 in pre-market trading.
• Stifel Nicolaus upgraded Power Integrations Inc POWI from Hold to Buy. Power Integrations shares fell 0.3% to close at $79.64 on Wednesday.
• Analysts at Sandler O'Neill upgraded United Financial Bancorp Inc UBNK from Hold to Buy. United Financial Bancorp closed at $14.05 on Wednesday.
• Janney Capital upgraded First Financial Northwest Inc FFNW from Neutral to Buy. First Financial Northwest shares rose 2.4% to close at $14.29 on Wednesday.

Top Downgrades

• Oppenheimer downgraded Waste Management, Inc. WM from Outperform to Perform. Waste Management shares fell 0.7% to $117.39 in pre-market trading.
• Longbow Research downgraded Allegheny Technologies Incorporated ATI from Buy to Neutral. Allegheny fell 1.7% to close at $24.45 on Wednesday.
• Bank of America downgraded Aurora Cannabis Inc ACB from Buy to Neutral. Aurora Cannabis shares fell 1.5% to $7.30 in pre-market trading.
• RBC Capital downgraded Exxon Mobil Corporation XOM from Outperform to Sector Perform. Exxon Mobil shares fell 0.4% to $75.21 in pre-market trading.
• Mizuho downgraded Advanced Micro Devices, Inc. AMD from Buy to Neutral. AMD shares fell 1.2% to $33.21 in pre-market trading.
• Jefferies downgraded Trade Desk Inc TTD from Buy to Hold. Trade Desk shares fell 0.9% to $242.00 in pre-market trading.
• Bernstein downgraded Air Products & Chemicals, Inc. APD from Outperform to Market Perform. Air Products shares fell 0.6% to $225.00 in pre-market trading.
• Barclays downgraded QUALCOMM, Inc. QCOM from Overweight to Equal-Weight. Qualcomm shares fell 1.3% to $74.80 in pre-market trading.
• Morgan Stanley downgraded MGM Resorts International MGM from Overweight to Equal-Weight. MGM shares fell 1.8% to $28.35 in pre-market trading.
• SVB Leerink downgraded Allergan plc AGN from Outperform to Market Perform. Allergan shares fell 0.3% to $162.00 in pre-market trading.

Top Initiations

• Oppenheimer initiated coverage on Acasti Pharma Inc ACST with an Outperform rating. The price target for Acasti Pharma is set to $7. Acasti Pharma shares closed at $1.37 on Wednesday.
• Analysts at Deutsche Bank initiated coverage on Blueprint Medicines Corp BPMC with a Buy rating. The price target for Blueprint Medicines is set to $110. Blueprint Medicines shares closed at $96.33 on Wednesday.
• H.C. Wainwright initiated coverage on Outlook Therapeutics Inc OTLK with a Buy rating. The price target for Outlook Therapeutics is set to $8. Outlook Therapeutics shares closed at $1.95 on Wednesday.
• Analysts at B. Riley FBR initiated coverage on Sonim Technologies Inc SONM with a Buy rating. The price target for Sonim Technologies is set to $17. Sonim Technologies shares closed at $13.75 on Wednesday.
• Analysts at Consumer Edge initiated coverage on SYSCO Corporation SYY with an Underweight rating. SYSCO shares closed at $71.75 on Tuesday.
• BMO Capital initiated coverage on Ingevity Corp NGVT with an Outperform rating. Ingevity shares closed at $101.29 on Wednesday.
• Analysts at Deutsche Bank initiated coverage on Deciphera Pharmaceuticals Inc DCPH with a Buy rating. The price target for Deciphera Pharmaceuticals is set to $42. Deciphera Pharmaceuticals shares closed at $20.55 on Wednesday.
• Citigroup initiated coverage on Clarivate Analytics PLC CCC with a Neutral rating. The price target for Clarivate Analytics is set to $17. Clarivate Analytics shares closed at $15.07 on Wednesday.